(4aR,6S,8aS)-6-acetyl-4a-hydroxy-4,8a-dimethyl-5,6,7,8-tetrahydro-1H-naphthalen-2-one

Details

Top
Internal ID 6b57d610-3bfd-4a86-ae1a-dfe182d4763e
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbonyl compounds > Cyclic ketones > Cyclohexenones
IUPAC Name (4aR,6S,8aS)-6-acetyl-4a-hydroxy-4,8a-dimethyl-5,6,7,8-tetrahydro-1H-naphthalen-2-one
SMILES (Canonical) CC1=CC(=O)CC2(C1(CC(CC2)C(=O)C)O)C
SMILES (Isomeric) CC1=CC(=O)C[C@]2([C@@]1(C[C@H](CC2)C(=O)C)O)C
InChI InChI=1S/C14H20O3/c1-9-6-12(16)8-13(3)5-4-11(10(2)15)7-14(9,13)17/h6,11,17H,4-5,7-8H2,1-3H3/t11-,13-,14-/m0/s1
InChI Key OQDPINWRWLARPI-UBHSHLNASA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C14H20O3
Molecular Weight 236.31 g/mol
Exact Mass 236.14124450 g/mol
Topological Polar Surface Area (TPSA) 54.40 Ų
XlogP 0.40
Atomic LogP (AlogP) 2.03
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4aR,6S,8aS)-6-acetyl-4a-hydroxy-4,8a-dimethyl-5,6,7,8-tetrahydro-1H-naphthalen-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.7968 79.68%
Blood Brain Barrier + 0.7000 70.00%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.8381 83.81%
OATP2B1 inhibitior - 0.8504 85.04%
OATP1B1 inhibitior + 0.9168 91.68%
OATP1B3 inhibitior + 0.9621 96.21%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior + 0.7500 75.00%
BSEP inhibitior - 0.8615 86.15%
P-glycoprotein inhibitior - 0.9761 97.61%
P-glycoprotein substrate - 0.8324 83.24%
CYP3A4 substrate + 0.5993 59.93%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8953 89.53%
CYP3A4 inhibition - 0.6255 62.55%
CYP2C9 inhibition - 0.8704 87.04%
CYP2C19 inhibition - 0.8330 83.30%
CYP2D6 inhibition - 0.9498 94.98%
CYP1A2 inhibition - 0.9420 94.20%
CYP2C8 inhibition - 0.9314 93.14%
CYP inhibitory promiscuity - 0.9395 93.95%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.5245 52.45%
Eye corrosion - 0.9946 99.46%
Eye irritation - 0.6014 60.14%
Skin irritation + 0.6694 66.94%
Skin corrosion - 0.9574 95.74%
Ames mutagenesis - 0.8060 80.60%
Human Ether-a-go-go-Related Gene inhibition - 0.6824 68.24%
Micronuclear - 0.8800 88.00%
Hepatotoxicity + 0.5625 56.25%
skin sensitisation + 0.4874 48.74%
Respiratory toxicity + 0.6222 62.22%
Reproductive toxicity + 0.9111 91.11%
Mitochondrial toxicity + 0.8750 87.50%
Nephrotoxicity - 0.5914 59.14%
Acute Oral Toxicity (c) III 0.5553 55.53%
Estrogen receptor binding - 0.6476 64.76%
Androgen receptor binding - 0.4904 49.04%
Thyroid receptor binding - 0.7902 79.02%
Glucocorticoid receptor binding - 0.6663 66.63%
Aromatase binding - 0.7028 70.28%
PPAR gamma - 0.8609 86.09%
Honey bee toxicity - 0.9054 90.54%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity + 0.9913 99.13%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.01% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.90% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.60% 96.09%
CHEMBL4224 P49759 Dual specificty protein kinase CLK1 89.05% 85.30%
CHEMBL1994 P08235 Mineralocorticoid receptor 88.26% 100.00%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 84.63% 93.04%
CHEMBL1937 Q92769 Histone deacetylase 2 83.57% 94.75%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.28% 99.23%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.27% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.25% 97.09%
CHEMBL2581 P07339 Cathepsin D 81.18% 98.95%
CHEMBL340 P08684 Cytochrome P450 3A4 80.54% 91.19%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.23% 95.56%

Cross-Links

Top
PubChem 71681103
NPASS NPC46206